Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Novartis
Queensland Health
Cerilliant
Cipla
Daiichi Sankyo
US Department of Justice
Deloitte
UBS
McKinsey

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,703,038

« Back to Dashboard

Summary for Patent: 4,703,038
Title: Combination of dihydropyridines with angiotensin converting enzymes-inhibitors
Abstract:The invention concerns a combination of dihydropyridine derivatives with compounds which inhibit the formation of enzymes which control the conversion of angiotensin I into angiotensin II and their use as antihypertensive agents.
Inventor(s): Garthoff; Bernward (Hilden, DE), Kazda; Stanislav (Wuppertal, DE), Knorr; Andreas (Wuppertal, DE)
Assignee: Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:06/785,182
Patent Claim Types:
see list of patent claims
Compound; Use; Process;

Drugs Protected by US Patent 4,703,038

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,703,038

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany3437917Oct 17, 1984

International Patents Family Members for US Patent 4,703,038

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 44650 ➤ Try a Free Trial
Australia 4840085 ➤ Try a Free Trial
Canada 1251733 ➤ Try a Free Trial
German Democratic Republic 239525 ➤ Try a Free Trial
Germany 3437917 ➤ Try a Free Trial
Germany 3571550 ➤ Try a Free Trial
Denmark 473585 ➤ Try a Free Trial
European Patent Office 0180785 ➤ Try a Free Trial
Spain 547931 ➤ Try a Free Trial
Spain 8703089 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Queensland Health
Boehringer Ingelheim
Colorcon
QuintilesIMS
McKinsey
Cipla
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot